Mv Capital Management, Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Mv Capital Management, Inc.
- $892 Million
- Q4 2024
A detailed history of Mv Capital Management, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Mv Capital Management, Inc. holds 50 shares of ALNY stock, worth $13,449. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 40
25.0%
Holding current value
$13,449
Previous $11,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ALNY
# of Institutions
671Shares Held
109MCall Options Held
1.23MPut Options Held
1.18M-
Capital World Investors Los Angeles, CA16.5MShares$4.44 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.43 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.57 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.41 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$1.13 Billion0.19% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.1B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...